Skip to main content

Advertisement

SpringerLink
Log in

Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Data from the Minnesota Breast Cancer Family Study cohort (n = 6,130 women) were used to examine the association of type II diabetes with mammographic percent density and incident breast cancer (BC). Exposures and outcomes were self-reported. The first set of analyses evaluated diabetes (DM) as a risk factor for breast cancer. A total of 403 women (6.6%) reported a diagnosis of type II diabetes and 333 women reported an incident breast cancer. Women who reported type II diabetes had an age-adjusted relative risk (RR) for breast cancer of 1.44 (95% CI 0.89–2.32) compared to those who did not. Adjustment for covariates strengthened the association (RR 1.61, 95% CI 0.98–2.62). Mammograms were retrieved on women over the age of 40 and percent density was estimated with a user-assisted thresholding program. Cross-sectional analyses revealed that mean levels of mammographic density were not statistically significantly different between diabetic and non-diabetic women. Results were similar within strata of menopausal status. Breast cancer cases with diabetes did not have a significantly higher percent density than cases without diabetes. Our findings suggest that breast cancer risk may be increased among women with type II diabetes, but that type II diabetes does not significantly influence mammographic breast density.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz G et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care 26:1752–1758

    Article  PubMed  Google Scholar 

  2. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307–314

    Article  PubMed  CAS  Google Scholar 

  3. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167

    Article  PubMed  Google Scholar 

  4. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26:781–785

    Article  PubMed  CAS  Google Scholar 

  5. Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM et al (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12:875–880

    Article  PubMed  CAS  Google Scholar 

  6. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349–352

    Article  PubMed  Google Scholar 

  7. O’Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38:435–441

    Article  PubMed  CAS  Google Scholar 

  8. Ragozzino M, Melton LJ, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13–19

    Article  PubMed  CAS  Google Scholar 

  9. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699–1703

    PubMed  CAS  Google Scholar 

  10. Sellers TA, Sprafka JM, Gapstur SM, Rich SS, Potter JD, Ross JA, McGovern PG et al (1994) Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology 5:102–108

    Article  PubMed  CAS  Google Scholar 

  11. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111

    Article  PubMed  CAS  Google Scholar 

  12. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD et al (2001) The relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263–274

    Article  PubMed  CAS  Google Scholar 

  13. Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111:293–297

    Article  PubMed  CAS  Google Scholar 

  14. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353

    Article  PubMed  CAS  Google Scholar 

  15. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14:2–19

    PubMed  CAS  Google Scholar 

  16. Li BD, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M et al (2001) Free insulin-like growth factor-I and breast cancer risk. Int J Cancer 91:736–739

    Article  PubMed  CAS  Google Scholar 

  17. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A et al (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828–832

    Article  PubMed  CAS  Google Scholar 

  18. Krajcik RA, Borofsky ND, Massardo S, Orentreich N (2002) Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11:1566–1573

    PubMed  CAS  Google Scholar 

  19. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393–1396

    Article  PubMed  CAS  Google Scholar 

  20. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:699–704

    Article  PubMed  CAS  Google Scholar 

  21. Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT et al (2004) Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 100:694–700

    Article  PubMed  CAS  Google Scholar 

  22. Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A et al (2006) IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13:593–605

    Article  PubMed  CAS  Google Scholar 

  23. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 13:583–592

    Article  PubMed  CAS  Google Scholar 

  24. Renehan AG, Harvie M, Howell A (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13:273–278

    Article  PubMed  CAS  Google Scholar 

  25. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144

    PubMed  CAS  Google Scholar 

  26. Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI, Present AJ et al (1985) The relationship between Wolfe’s classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am J Epidemiol 122:994–1006

    PubMed  CAS  Google Scholar 

  27. Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC (1995) Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 142:813–819

    PubMed  CAS  Google Scholar 

  28. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control, 11:653–662

    Article  PubMed  CAS  Google Scholar 

  29. Maskarinec G, Williams AE, Kaaks R (2003) A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 107:991–996

    Article  PubMed  CAS  Google Scholar 

  30. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60:3744–3748

    PubMed  CAS  Google Scholar 

  31. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886–894

    Article  PubMed  Google Scholar 

  32. Berube S, Diorio C, Verhoek-Oftedahl W, Brisson J (2004) Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 13:1466–1472

    PubMed  CAS  Google Scholar 

  33. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1065–1073

    Article  PubMed  CAS  Google Scholar 

  34. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E et al (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10:243–248

    PubMed  CAS  Google Scholar 

  35. Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P et al (2003) Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev 12:552–558

    PubMed  Google Scholar 

  36. Sellers TA, Anderson VE, Potter JD, Bartow SA, Chen PL, Everson L et al (1995) Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genetic Epidemiol 12:417–429

    Article  CAS  Google Scholar 

  37. Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH et al (1999) Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev 8:1051–1057

    PubMed  CAS  Google Scholar 

  38. Weaver TW, Kushi LH, McGovern PG, Potter JD, Rich SS, King RA et al (1996) Validation study of self-reported measures of fat distribution. Int J Obes Relat Metab Disord 20:644–650

    PubMed  CAS  Google Scholar 

  39. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638

    Article  PubMed  CAS  Google Scholar 

  40. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1996) Automated analysis of mammographic densities. Phys Med Biol 41:909–923

    Article  PubMed  CAS  Google Scholar 

  41. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes – a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241:471–475

    Article  PubMed  CAS  Google Scholar 

  42. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM et al (2000) Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 284:1791–1798

    Article  PubMed  CAS  Google Scholar 

  43. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80

    PubMed  CAS  Google Scholar 

  44. Fisher LD, Lin DY (1999) Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20:145–157

    Article  PubMed  CAS  Google Scholar 

  45. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Statistics for biology and health. Springer, New York

    Google Scholar 

  46. Strange KS, Wilkinson D, Edin G, Emerman JT (2004) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture. Breast Cancer Res Treat 84:77–84

    Article  PubMed  CAS  Google Scholar 

  47. Strange KS, Wilkinson D, Emerman JT (2002) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast epithelial cells in primary culture. Breast Cancer Res Treat 75:203–212

    Article  PubMed  CAS  Google Scholar 

  48. Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44–54

    Article  PubMed  CAS  Google Scholar 

  49. Dunger DB, Ong KK, Sandhu M (2003) Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes. Horm Res 60(Suppl 3):131–135

    Article  PubMed  CAS  Google Scholar 

  50. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H (1999) Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314–322

    Article  PubMed  CAS  Google Scholar 

  51. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296:193–201

    Article  PubMed  CAS  Google Scholar 

  52. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE et al (2005) Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 14:656–661

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Prevention and Control, H. Lee Moffitt Cancer & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA

    Thomas A. Sellers & Anna R. Giuliano

  2. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA

    Leif E. Jensen, Robert A. Vierkant, Zachary S. Fredericksen, Vernon S. Pankratz, James R. Cerhan & Celine M. Vachon

  3. Department of Radiology, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA

    Kathleen R. Brandt

Authors
  1. Thomas A. Sellers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leif E. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert A. Vierkant
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zachary S. Fredericksen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kathleen R. Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna R. Giuliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vernon S. Pankratz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. James R. Cerhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Celine M. Vachon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas A. Sellers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sellers, T.A., Jensen, L.E., Vierkant, R.A. et al. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control 18, 505–515 (2007). https://doi.org/10.1007/s10552-007-0128-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-007-0128-9

Keywords

Search

Navigation